Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Shares Outstanding (Weighted Average) (2016 - 2026)

Bio-Techne has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $155.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 1.67% year-over-year to $155.8 million; the TTM value through Dec 2025 reached $155.8 million, down 1.67%, while the annual FY2025 figure was $157.5 million, 0.12% changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $155.8 million at Bio-Techne, roughly flat from $155.5 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $158.5 million in Q3 2024 and troughed at $38.9 million in Q1 2021.
  • A 5-year average of $139.4 million and a median of $157.1 million in 2022 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 305.71% in 2021 and later decreased 1.93% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $39.3 million in 2021, then soared by 299.42% to $157.0 million in 2022, then increased by 0.33% to $157.5 million in 2023, then increased by 0.6% to $158.5 million in 2024, then fell by 1.67% to $155.8 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for TECH at $155.8 million in Q4 2025, $155.5 million in Q3 2025, and $157.5 million in Q2 2025.